Vaccines do more than prevent the diseases they target.
In the ongoing human effort to understand what harms us and why, researchers at Murdoch Children's Research Institute have built a platform that listens more carefully than we have before — and in doing so, discovered that vaccines protect us in ways we never knew to measure. The E-HOMER initiative, through its SnotWatch surveillance arm, has begun revealing hidden connections between common respiratory viruses and conditions like febrile seizures and heart events, quietly expanding the known value of vaccination. It is a reminder that the full consequences of illness — and the full benefits of prevention — often exceed what we first imagine, waiting only for the right instrument to make them visible.
- Vaccines against flu and RSV have been quietly preventing febrile seizures in children all along — a benefit that went unrecognised until surveillance data finally made the connection visible.
- The gap between what doctors know and what patients need to hear is real: without local, real-time data, conversations about vaccination and antibiotic stewardship rest on general advice rather than concrete evidence.
- SnotWatch is closing that gap by pairing PCR test results with health outcome data across populations, building a living picture of what viruses are doing in communities right now.
- GPs are soon to receive localised dashboards and alerts — tools that will let them point to neighbourhood-level data when recommending vaccines or explaining why antibiotics won't help.
- The research team is scaling the framework nationally and building patient-facing platforms, turning a surveillance project into a broad public health instrument for anticipating and responding to viral disease.
Researchers at Murdoch Children's Research Institute set out to track how viruses move through communities — and found something they weren't looking for. Their E-HOMER initiative, through a respiratory surveillance arm called SnotWatch, collects de-identified PCR test results and pairs them with health outcome data from the same individuals. The result is a platform capable of showing, in near real-time, what a circulating virus actually does to a population.
What it revealed was unexpected. Both influenza and RSV turned out to be associated with febrile seizures — fever-induced convulsions in young children — a connection no one had previously established. The implication is significant: vaccines against these viruses don't only prevent the infections themselves. They also prevent the downstream conditions those infections trigger. Research coordinator Dr Aaron Weinman calls this a "novel benefit" of vaccination, and sees it as the first of many such discoveries. The platform is already examining links between viral circulation and conditions ranging from myocardial infarctions to Kawasaki disease.
For general practitioners, the practical value is immediate. SnotWatch will soon deliver localised dashboards showing which viruses are active in a GP's specific area, updated continuously. This transforms the clinical conversation — a doctor can point to neighbourhood-level data when recommending a vaccine, or when explaining to a patient why antibiotics won't address what's circulating this week. It also helps practices anticipate seasonal surges and manage resources before demand peaks.
Partnerships with major pathology laboratories are already in place. Online platforms for both clinicians and patients are in development, and the team is working to demonstrate that the SnotWatch model can scale across jurisdictions. What began as a watching project has grown into something larger: a way of seeing the full picture of what viruses cost us — and what preventing them is truly worth.
In the quiet work of tracking what moves through a community—the viruses that spread from person to person, season to season—researchers at Murdoch Children's Research Institute have stumbled onto something unexpected: vaccines do more than prevent the diseases they target. They prevent other things too, things no one quite realized they were preventing until the data made it visible.
The project is called E-HOMER, the Ecologic Health Outcome Monitoring Environment Reporting initiative. Its respiratory arm, SnotWatch, does something deceptively simple: it watches. It collects de-identified results from PCR tests—the swabs that tell you whether someone has flu or RSV or any of a dozen other respiratory viruses—and it pairs those results with health outcome data from the same people. The result is a large, rich platform that can show, in near real-time, what happens when a virus circulates through a population.
What they found was striking. Influenza and RSV, both viruses we have vaccines for, turned out to be associated with febrile seizures—convulsions brought on by fever in young children. No one had connected these dots before. The implication is straightforward: vaccinating against flu and RSV doesn't just prevent flu and RSV. It also prevents febrile seizures. That's a benefit that existed all along, hidden in the noise of the data, waiting for someone to look carefully enough to see it.
Dr Aaron Weinman, the research coordinator leading the work, describes this as a "novel benefit" of vaccination—a previously unknown reason to get the shot. And he sees it as the first of many such discoveries. The platform is already examining connections between viral circulation and a long list of conditions: myocardial infarctions, chilblains, hepatitis, asthma, Kawasaki disease, bacterial infections. Each connection uncovered is another argument for vaccination, another piece of evidence to place in front of a patient who is deciding whether the shot is worth it.
For general practitioners, this matters in concrete ways. SnotWatch will soon provide dashboards and alerts showing which viruses are circulating in their local area, updated continuously. A GP will be able to tell a patient not just "there's flu going around" but "here's what we're seeing in our neighborhood right now, and here's what we expect to see in the coming weeks." That kind of information changes how a doctor talks to patients. It gives weight to the recommendation. It also helps with the harder conversations—the ones where a patient comes in with a cough and wants antibiotics, and the doctor needs to explain that this is viral, that antibiotics won't help, that what they need is time and rest. When the GP can point to local surveillance data showing that RSV is the dominant virus this week, that conversation becomes easier.
There's another layer to this. Seasonal peaks strain healthcare systems. If a practice knows that flu season is arriving early, or that a particular virus is rising faster than expected, they can prepare. They can anticipate demand. They can staff accordingly. The data becomes a tool for resource management, not just for individual patient care but for the whole practice.
The researchers have already established partnerships with major pathology laboratories to access the test results they need. They're now building the online platforms that will put this information into GPs' hands—dashboards, trend summaries, local alerts. They're also creating resources for patients, interactive platforms where people can learn what viruses are circulating and what that means for their health. And they're working with other jurisdictions to show that the SnotWatch framework works beyond its home base, that it can be scaled, that it can become part of how we understand and respond to viral disease across a whole country.
What started as a surveillance project—a way to watch viruses move through communities—has become something more: a tool for making the case for vaccination, for improving how doctors talk to patients, for helping healthcare systems prepare for what's coming. The viruses will keep circulating. But now, for the first time, we're beginning to see the full picture of what they do.
Citações Notáveis
By continuously monitoring this platform, we will learn more about the previously unknown consequences of virus circulation.— Dr Aaron Weinman, MCRI Research Coordinator
We have found that viruses we have vaccines against are associated with conditions that we don't have vaccines against. For example, influenza and RSV were associated with febrile seizures.— Dr Aaron Weinman, MCRI Research Coordinator
A Conversa do Hearth Outra perspectiva sobre a história
So this project watches viruses. But why does it matter that we know which viruses are circulating right now, in real-time? Isn't that just epidemiology?
It's epidemiology, yes, but with a crucial difference. Most surveillance tells you what's spreading. SnotWatch tells you what spreading causes. It connects the virus to the actual health outcomes in the same people. That's the leap.
And they found that flu and RSV cause febrile seizures? That seems like something we would have known.
You'd think so. But the connection was hidden in the noise. You'd need to look at thousands of cases, match the test results to the health records, and ask the right question. No one had done that systematically before. Once you see it, it's obvious. But before you see it, it's invisible.
What does a GP actually do with this information?
They get a dashboard showing what's circulating locally this week. When a parent asks about flu, the doctor can say "yes, we're seeing a lot of it right now." But more importantly, they can say "and here's why vaccination matters—it prevents not just the flu, but also these complications." That's a conversation changer.
Does this help with antibiotic overuse?
Directly, yes. When a GP can point to data showing RSV is dominant this week, they can tell a patient with confidence: this is viral, antibiotics won't help. The data gives them authority. It's not just opinion anymore.
What happens next?
They're building dashboards for GPs and patient-facing platforms. They're expanding to other jurisdictions. And they're looking at more conditions—heart attacks, asthma, other things that might be linked to viral circulation. Every connection they find is another reason to vaccinate.